SOLVAY S.A. A/ BE0003470755 /
8/16/2024 8:09:45 AM | Chg. +0.380 | Volume | Bid8:54:08 PM | Ask8:54:08 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
30.930EUR | +1.24% | 0 Turnover: 0.000 |
-Bid Size: - | -Ask Size: - | 3.24 bill.EUR | 7.87% | 1.54 |
GlobeNewswire
10/25/2023
NobleAI Announces Groundbreaking Collaboration with Microsoft Azure Quantum Elements
GlobeNewswire
10/12/2023
NobleAI’s Science-Based AI Technology to be Highlighted at SPE Annual Technical Conference and Expos...
GlobeNewswire
10/7/2023
CERN Inaugurates Science Gateway, Its New Outreach Centre for Science Education
GlobeNewswire
9/19/2023
Radix Engineering Expands US Operations, Appoints Alexander Clausbruch North America CEO
GlobeNewswire
9/7/2023
NobleAI Launches New AI-Powered Chemical and Materials Informatics Solutions on Microsoft’s Azure Ma...
GlobeNewswire
2/17/2022
Bluebell Capital Partners - Response to Solvay Board Open Letter Regarding Soda Ash Operations in Ro...
GlobeNewswire
1/11/2022
Western Rare Earths Announced as Team Member of the US Critical Materials Institute; Partner to DOE ...
GlobeNewswire
3/29/2021
Solvay’s Kadri will Present Keynote Lecture at AIChE’s Virtual Spring Meeting & Global Congress on P...
GlobeNewswire
10/1/2020
Intra-Cellular Therapies Announces the Appointment of Dr. Suresh Durgam as Chief Medical Officer